3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Recruiting
2
Unknown
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Breast
25
Gastrointestinal
24
Head & Neck
8
Other hematologic neoplasm
7
Thoracic
4
Sarcoma
3
Plasma cell
3
Lymphoid
3
Classical hematology
3
Myeloid
2
Other neoplasm
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Sarcoma
956
Glioblastoma
299
Gliosarcoma
288
Osteosarcoma
285
Brain Neoplasms
195
Dendritic Cell Sarcoma, Interdigitating
188
Gastrointestinal Stromal Tumors
179
Bone Neoplasms
170
Lymphoma
160
Central Nervous System Neoplasms
160
Astrocytoma
155
Sarcoma, Ewing
149
Glioma
148
Precursor Cell Lymphoblastic Leukemia-Lymphoma
147
Lymphoma, Non-Hodgkin
143
Burkitt Lymphoma
139
Neoplasms
137
Recurrence
134
Lymphoma, Large B-Cell, Diffuse
128
Lymphoma, Follicular
128
Neuroblastoma
126
Rhabdomyosarcoma
125
Hodgkin Disease
124
Oligodendroglioma
123
Breast Neoplasms
122
Lymphoma, Mantle-Cell
117
Leukemia, Myeloid, Acute
117
Leukemia, Lymphocytic, Chronic, B-Cell
117
Lymphoma, B-Cell, Marginal Zone
113
Leukemia
111
Interventions
Standard of Care
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
talazoparib
1
sarilumab
1
regorafenib
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
durvalumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Transurethral Resection of Bladder
1
STA 9090
1
SGN-LIV1A
1
Paclitaxel
1
MK 2206
1
Letrozole
1
Lasofoxifene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
OTHER
×
Pathologic Complete Response
×
Sarcoma
×
Clear all
NCT01042379
2026-05-06
I-SPY
QuantumLeap Healthcare Collaborative
Phase 2
Recruiting
5,000 enrolled
NCT04055220
2026-02-17
REGOSTA
Centre Leon Berard
Phase NA
Recruiting
168 enrolled
NCT05684874
2023-10-30
SarQuantIRM
Centre Leon Berard
Phase NA
Unknown
25 enrolled